Blockade of Cardiac Potassium and Other Channels by Antihistamines
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 21 (1) , 11-18
- https://doi.org/10.2165/00002018-199921001-00003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5British Journal of Pharmacology, 1997
- Comparative Effects of Loratadine and Terfenadine on Cardiac K+ ChannelsJournal of Cardiovascular Pharmacology, 1997
- Risks of non-sedating antihistaminesThe Lancet, 1997
- Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channelsEuropean Journal of Pharmacology, 1997
- Suppression of Mammalian K+ Channel Family by EbastineThe Journal of Pharmacology and Experimental Therapeutics, 1997
- Multiple Mechanisms in the Long-QT SyndromeCirculation, 1996
- Terfenadine Blocks Time-Dependent Ca2+, Na+, and K+ Channels in Guinea Pig Ventricular MyocytesJournal of Cardiovascular Pharmacology, 1995
- Regulation of Potassium Channels by Nonsedating AntihistaminesCirculation, 1995
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- Cardiac Electrophysiological Actions of the Histamine H 1 -Receptor Antagonists Astemizole and Terfenadine Compared With Chlorpheniramine and PyrilamineCirculation Research, 1995